FSD Episode: Escape Longevity — Peptides, Wealth & the Buy-Borrow-Die Playbook (with Matt Goldstein)
In this FSD episode, we sit down with Matt Goldstein, Chief Investment Officer at Exit Wealth, for our first-ever special-guest conversation on where health, longevity, and money collide. We start with the GLP revolution and make the case that health is still the most underestimated investment there is — a healthy man has a thousand problems, a sick man has only one.
From there we get into "escape longevity" — the idea that we may soon add more than a year of life for every year we live — and what it does to insurance, annuities, and a Social Security system built for a world where people died at 70.
The portfolio conclusion is blunt: if you're going to live 50 more years, 60/40 is dead, and stocks are the only assets with enough duration to fund that life.
We then break down the tactical playbook of the ultra-wealthy — "buy, borrow, die," box spreads that let you borrow near the government yield curve tax-deductibly, and the family office that turned a $10M .The back half turns to peptides and personalized medicine,, not health care," and how to actually play the trend (EliLilly, hims).
We close on culture and AI: how GLPs are quietly killing alcohol and bars, why human connection becomes the scarce "anti-AI trade," and a genuinely humbling encounter with Claude.